<p>(A) Chemical structures of the obligate chain terminator 3′dGTP and the base-modified T-705 ribofuranosyl 5′-triphosphate (T-705 RTP). (B) Polyacrylamide gel electrophoresis (6%) showing the decrease in radiolabeled viral RNA product from the enzymatic reaction in the presence of increasing concentrations of 3′dGTP. Concentrations of inhibitor are as follows: lane 1 (0), lane 2 (0.023), lane 3 (0.069), lane 4 (0.21), lane 5 (0.62), lane 6 (1.9), lane 7 (5.6), lane 8 (16.7), lane 9 (50), and lane 10 (150 µM). (C) same as (B), with the same concentration range of T-705 RTP as inhibitor.</p
<p>The minimal inhibitory concentration of RpSP-D and NpSP-D required to inhibit the hemagglutinatio...
Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1,...
Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1,...
The nucleobase analogue T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide; favipiravir) is a unique an...
T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical developm...
<p>Enzyme kinetics of single nucleotide incorporation combined with competitive inhibition experimen...
We here disclose chemical synthesis of ribonucleoside 5′-monophosphate (RMP), -diphosphate (RDP), an...
T-705 (favipiravir) is a new antiviral agent in advanced clinical development for influenza therapy....
<p>(<b>A</b>) Effect of low (1 μM) and high (100 μM) concentration of ATP, UTP, CTP, or GTP, on inhi...
Influenza polymerase is a heterotrimer protein with both endonuclease and RNA-dependent RNA polymera...
RNA-dependent RNA polymerase (RdRP) is essential for the replication and expression of RNA viral gen...
The antiviral drug T-705 (favipiravir) and its non-fluorinated analogue T-1105 inhibit the polymeras...
<div><p>Influenza polymerase is a heterotrimer protein with both endonuclease and RNA-dependent RNA ...
Halogenated nucleosides such as 5'-fluoro and 5 'iodo-2- 'deoxyuridine have been usef...
Treatment with the nucleoside analog T-1106 was previously shown to be effective in a hamster model ...
<p>The minimal inhibitory concentration of RpSP-D and NpSP-D required to inhibit the hemagglutinatio...
Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1,...
Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1,...
The nucleobase analogue T-705 (6-fluoro-3-hydroxy-2-pyrazinecarboxamide; favipiravir) is a unique an...
T-705 (Favipiravir) is a broad-spectrum antiviral molecule currently in late stage clinical developm...
<p>Enzyme kinetics of single nucleotide incorporation combined with competitive inhibition experimen...
We here disclose chemical synthesis of ribonucleoside 5′-monophosphate (RMP), -diphosphate (RDP), an...
T-705 (favipiravir) is a new antiviral agent in advanced clinical development for influenza therapy....
<p>(<b>A</b>) Effect of low (1 μM) and high (100 μM) concentration of ATP, UTP, CTP, or GTP, on inhi...
Influenza polymerase is a heterotrimer protein with both endonuclease and RNA-dependent RNA polymera...
RNA-dependent RNA polymerase (RdRP) is essential for the replication and expression of RNA viral gen...
The antiviral drug T-705 (favipiravir) and its non-fluorinated analogue T-1105 inhibit the polymeras...
<div><p>Influenza polymerase is a heterotrimer protein with both endonuclease and RNA-dependent RNA ...
Halogenated nucleosides such as 5'-fluoro and 5 'iodo-2- 'deoxyuridine have been usef...
Treatment with the nucleoside analog T-1106 was previously shown to be effective in a hamster model ...
<p>The minimal inhibitory concentration of RpSP-D and NpSP-D required to inhibit the hemagglutinatio...
Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1,...
Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1,...